EUVIMEDEUVIMED entdecken
Crossref

Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway

Junyi Chen, Shuzhan Yang, Hanxia Luo, Xinliang Fu, Wanyan Li, Bingxin Li, Cheng Fu, Feiyue Chen, Danning Xu, Nan Cao

International Immunopharmacology · 2024-11 · 141 · 113014

DOI: 10.1016/j.intimp.2024.113014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-11. Verfasst von Junyi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Zhongkai University of Agriculture and Engineering, Guangzhou, Guangdong 510225, China. Hauptthemen laut MEDLINE: Atractylodes, Toll-Like Receptor 4, Myeloid Differentiation Factor 88, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) not only could cause abnormal lipid metabolism in the liver, but also could cause liver inflammation. Previous studies have shown that Polysaccharide of Atractylodes macrocephala Koidz (PAMK) could alleviate animal liver inflammatory damage and alleviate NAFLD in mice caused by high-fat diet(HFD), but regulation of liver inflammation caused by NAFLD has rarely been reported. In this study, an animal model of non-alcoholic fatty liver inflammation in the liver of mice was established to explore the protective effect of PAMK on the liver of mice. The results showed that PAMK could alleviate the abnormal increase of body weight and liver weight of mice caused by HFD, alleviate the abnormal liver structure of mice, reduce the level of oxidative stress and cytokine secretion in the liver of mice, and downregulate the mRNA expression of TLR4, MyD88, NF-κB and protein expression of P-IκB, P-NF-κB-P65, TLR4, MyD88, NF-κB in the liver. These results indicate that PAMK could alleviate hepatocyte fatty degeneration and damage, oxidative stress and inflammatory response of the liver caused by NAFLD in mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtractylodesToll-Like Receptor 4Myeloid Differentiation Factor 88Non-alcoholic Fatty Liver DiseaseNF-kappa BSignal TransductionPolysaccharidesLiverDiet, High-FatAnimalsMiceMaleOxidative StressDisease Models, AnimalCytokinesMice, Inbred C57BLAnti-Inflammatory Agents

Stichwörter der Autor:innen

InflammationMiceNonalcoholic fatty liver diseasePAMKTLR4

Substanzen

Toll-Like Receptor 4Myeloid Differentiation Factor 88NF-kappa BTlr4 protein, mousePolysaccharidesMyd88 protein, mouseCytokinesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • College of Animal Science and Technology, Zhongkai University of Agriculture and Engineering, Guangzhou, Guangdong 510225, China.
  • Technology Center, Guangzhou Customs, Guangzhou, Guangdong 510623, China.
  • College of Animal Science and Technology, Zhongkai University of Agriculture and Engineering, Guangzhou, Guangdong 510225, China. Electronic address: ncao2017@163.com.

Zitieren

APA

Chen, J., Yang, S., Luo, H., Fu, X., Li, W., Li, B., Fu, C., Chen, F., Xu, D., & Cao, N. (2024). Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway. International Immunopharmacology, 141, 113014. https://doi.org/10.1016/j.intimp.2024.113014

Vancouver

Chen J, Yang S, Luo H, Fu X, Li W, Li B, et al. Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway. International Immunopharmacology. 2024;141:113014. doi:10.1016/j.intimp.2024.113014

BibTeX
@article{Chen2024,
  author = {Chen, Junyi and Yang, Shuzhan and Luo, Hanxia and Fu, Xinliang and Li, Wanyan and Li, Bingxin and Fu, Cheng and Chen, Feiyue and Xu, Danning and Cao, Nan},
  title = {Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {141},
  pages = {113014},
  doi = {10.1016/j.intimp.2024.113014}
}
Kostenlos starten →